Summary of the 12th Nikolas Symposium dendritic cell differentiation: Signals, signaling and functional consequences as clues to possible therapy

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 3, 2003, Pages 193-197

  Nichols, Kim E ^a   Egeler, R Maarten ^b   Perry, V Hugh ^c   Arceci, Robert ^d  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD40 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE RECEPTOR; FENRETINIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; KI 67 ANTIGEN; LANGERIN; LECTIN; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN P16; PROTEIN P21; PROTEIN P53; PROTEIN P55; RETINOIC ACID; SYNAPTOPHYSIN; T6 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; UVOMORULIN;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE DIFFERENTIATION; CELL DIFFERENTIATION; CELL INFILTRATION; CONFERENCE PAPER; DENDRITIC CELL; EOSINOPHIL; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTE; HISTIOCYTOSIS X; HUMAN; JUVENILE XANTHOGRANULOMA; LANGERHANS CELL; MACROPHAGE; MEGAKARYOCYTE; MONOCYTE; NEUROBLASTOMA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

CELL DIFFERENTIATION; DENDRITIC CELLS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LANGERHANS CELLS;

EID: 0037334817     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200303000-00003     Document Type: Conference Paper

References (31)

1. Arico M, Egeler RM. Clinical Aspects of Langerhans Cell Histiocytosis. Hematol Oncol Clin N Amer 1998;12:247-258.
2. Schmitz L, Favara BE. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin N Amer 1998;12:221-246.
3. Komp DM. Long-term sequelae of histiocytosis X. Am J Pediatr Hematol Oncol 1981;3:163-168.
4. Nanduri VR, Bareille P, Pritchard J, et al. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf) 2000;53:509-515.
5. Tallman MS, Nabhan C, Feusner JH, et al. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 2002;99:759-767.
6. Reynolds CP, Lemons RS. Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 2001;15:867-910.
7. Canque B, Camus S, Dalloul A, et al. Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells. Blood 2000;96:3748-3756.
8. Canque B, Gluckman JC. Toward a unified theory of dendritic cell diversity. Trends Immunol 2001;22:664.
9. Gluckman JC, Canque B, Rosenwajg M. Dendritic cells: a complex simplicity. Transplantation 2002;73:S3-S6.
10. St Louis DC, Woodcock JB, Fransozo G, et al. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. J Immunol 1999;162:3237-3248.
11. Davis TA, Saini AA, Blair PJ, et al. Phorbol esters induce differentiation of human CD34+ hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling. J Immunol 1998;160:3689-3697.
12. Riedl E, Stockl J, Majdic O, et al. Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood 2000; 96:4276-4284.
13. Ohishi K, Varnum-Finney B, Bernstein ID. The notch pathway: modulation of cell fate decisions in hematopoiesis. Int J Hematol 2002;75:449-459.
14. Ohishi K, Varnum-Finney B, Flowers D, et al. Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. Blood 2000;95:2847-2854.
15. Ohishi K, Varnum-Finney B, Serda RE, et al. The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood 2001;98:1402-1407.
16. Geissmann F, Lepelletier Y, Fraitag S, et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001;97:1241-1248.
17. Egeler RM, Favara BE, Laman JD, et al. Abundant expression of CD40 and CD40-ligand (CD154) in pediatric Langerhans cell histiocytosis lesions. Eur J Cancer 2000;36:2105-2110.
18. Andreakos E, Smith C, Monaco C, et al. IkB kinase 2 but not NF-kB-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction. Blood 2003;101:983-991.
19. Horwood NJ, Smith C, Andreakos E, et al. High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets. Arthritis Res 2002;4:S215-S225.
20. Jefford M, Maraskovsky E, Cebon J, et al. The use of dendritic cells in cancer therapy. Lancet Oncol 2001;2:343-353.
21. Maraskovsky E, Daro E, Roux E, et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 2000;96:878-884.
22. Luft T, Jefford M, Luetjens P, et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 2002;100:1362-1372.
23. Favara BE, Jaffe R, Egeler RM. Macrophage activation and hemophagocytic syndrome in Langerhans cell histiocytosis. Pediatr Dev Pathol 2002;5:130-140.
24. Geissmann F, Emile JF, Andry P, et al. Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J Pathol 1997;181:301-304.
25. Leenen PJ, Egeler RM. Langerhans' cell histiocytosis is caused by dysregulation of the E-cadherin-beta-catenin cascade: a hypothesis. Immunol Cell Biol 1999; 77:460-467.
26. Sozzani S, Allavena P, Vecchi A, et al. The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol 1999;66:1-9.
27. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-127.
28. Bhatia S, Nesbit ME Jr., Egeler RM, et al. Epidemiologic study of Langerhans cell histiocytosis in children. J Pediatr 1997;130:774-784.
29. Hamre M, Hedberg J, Buckley J, et al. Langerhans cell histiocytosis: an exploratory epidemiologic study of 177 cases. Med Pediatr Oncol 1997;28:92-97.
30. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease. N Engl J Med 1994;331:154-160.
31. Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001;25:630-636.